Pro- and anti-inflammatory cytokine balance in major depression: Effect of sertraline therapy
Clinical and Developmental Immunology, cilt.2007, 2007 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 2007
- Basım Tarihi: 2007
- Doi Numarası: 10.1155/2007/76396
- Dergi Adı: Clinical and Developmental Immunology
- Derginin Tarandığı İndeksler: Scopus
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment. Copyright © 2007 Levent Sutcigil et al.